US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold. The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Generic Drugs MarketThe global Generic Drugs market size is projected to reach US$ 505220 million by 2026, from US$ 285180 million in 2020, at a CAGR of 10.0% during 2021-2026.
Global Generic Drugs Scope and SegmentGeneric Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
- Novartis - Sandoz
- Sun Pharmaceutical
- Fresenius Kabi
- Pfizer (Hospira)
- Dr. Reddys
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Bausch Health
- Zydus Cadila
Generic Drugs Breakdown Data by Type
- Simple Generic Drugs
- Super Generic Drugs
Generic Drugs Breakdown Data by Application
- Genitourinary/Hormonal Drugs
Table of Contents Chapter 1. Preface 1.1. Report Description 1.1.1. Objective 1.1.2. Target Audience 1.1.3. Unique Selling Proposition (USP) & Offerings 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology 1.3.3. Level 1: Primary Research 1.3.4. Level 2: Secondary Research 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope Chapter 2. Executive Summary 2.1. Global Generic Drugs 2019-2029 (USD Billion) 2.2. Global Generic Drugs: Market Snapshot Chapter 3. Global Generic Drugs - Industry Analysis | read more...